Company Filing History:
Years Active: 2019
Title: Ian Michael Hunneyball: Innovator in Sleep Disorder Treatments
Introduction
Ian Michael Hunneyball is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of pharmacology, particularly in the treatment of sleep disorders. His innovative approach has led to the development of a unique pharmaceutical compound aimed at alleviating insomnia.
Latest Patents
Hunneyball holds a patent for the treatment of sleep disorders. The patent details the use of 7-chloro-3-(5-dimethylaminomethyl-[1,2,4]oxadiazol-3-yl)-5methyl-4,5-dihydro-imidazol[1,5,-a][1,4]benzodiazepine-6-one or its pharmaceutically acceptable salt for treating various types of insomnia. This invention represents a significant advancement in the management of sleep-related issues.
Career Highlights
Hunneyball is currently associated with Evotec International GmbH, a company known for its commitment to drug discovery and development. His work at Evotec has allowed him to collaborate with leading experts in the field, enhancing the impact of his research and innovations.
Collaborations
Some of his notable coworkers include John Alan Kemp and Timothy Tasker. Their collective expertise contributes to the advancement of research and development in the pharmaceutical industry.
Conclusion
Ian Michael Hunneyball's contributions to the treatment of sleep disorders highlight his role as an innovative inventor in the pharmaceutical field. His patent and ongoing work at Evotec International GmbH demonstrate his commitment to improving the quality of life for individuals suffering from insomnia.